A prospective study to evaluate safety and efficacy of intracoronary bivalirudin administration during primary percutaneous coronary interventions (PCI) in comparison with heparin and provisional GP2b3a inhibitors standard treatment.
Phase of Trial: Phase II
Latest Information Update: 23 Dec 2015
At a glance
- Drugs Bivalirudin (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 23 Dec 2015 New trial record